(sunitinib malate) is a new, oral, multikinase inhibitor for patients
with advanced renal cell carcinoma (RCC),* and gastrointestinal
stromal tumor (GIST) after disease progression on, or intolerance
to, imatinib mesylate.
the first non-stimulant medication that's FDA-approved to treat
ADHD in children, adolescents, and adults - available by prescription
10 mg-Film-coated 30, 50 or 100 tablets
of patients with moderately severe to severe Alzheimer's disease.
Fuzeon (enfuvirtide) is a new class of anti-HIV medication. It
is in a category of HIV medicines called fusion inhibitors, or
more broadly, entry inhibitors. Fuzeon binds to a protein on HIV's
surface called gp41. Once it does this, HIV cannot successfully
bind with the surface of T-cells, thus preventing the virus from
infecting healthy cells. Fuzeon will most likely need to be used
in combination with other anti-HIV drugs.
is the first nonsteroid topical immunomodulator (TIM) for moderate
to severe atopic dermatitis.
is a prescription medicine for the acute treatment of migraine
attacks, with or without aura, in adults.
the information provided from Roser Miro Pharmacy's Web is directed
to complement, not to substitute the existent relationship between
a patient and his or her doctor.
Privacy and confidentiality
policy: Whatever communication conveyed through the Web of Roser Miró
Pharmacy is strictly confidential; although the electronic addresses
and their content can be kept, your information will not be shared
with any external source.
This Web is managed by Roser Miró pharmacy, legally established
in Escaldes, Principality of Andorra. The terms and conditions of
usage of this Web are protected under the laws that rule in Andorra.
Equally all its products and medicines have been authorized by the
Health and Social Health Ministry of the Government of Andorra.
Links: The Web
of the pharmacy contains links to other Webs, normally those of the
labs which manufacture the different products. These links are offered
as services and information to provide the maximum information about
the products, medicines and treatments, relative to health and well-being.
advertising: This Web neither receives nor has any financing from
of this web has been produced by the pharmacists of Roser Miró
Pharmacy's team, starting from approvals and subsequent information
from the European medicines agency www.emea.europa.eu
and the USA Food and Drug administration www.fda.gov
and from the manufacturing pharmaceutical laboratories.